675 related articles for article (PubMed ID: 26388185)
21. Topical antibiotic treatment reduces tympanostomy tube biofilm formation.
Thomas RG; Ojano-Dirain C; Antonelli PJ
Laryngoscope; 2011 May; 121(5):1067-71. PubMed ID: 21437915
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial activity of biogenically produced spherical Se-nanomaterials embedded in organic material against Pseudomonas aeruginosa and Staphylococcus aureus strains on hydroxyapatite-coated surfaces.
Piacenza E; Presentato A; Zonaro E; Lemire JA; Demeter M; Vallini G; Turner RJ; Lampis S
Microb Biotechnol; 2017 Jul; 10(4):804-818. PubMed ID: 28233476
[TBL] [Abstract][Full Text] [Related]
23. Anti-Biofilm Effects of Synthetic Antimicrobial Peptides Against Drug-Resistant
Park SC; Lee MY; Kim JY; Kim H; Jung M; Shin MK; Lee WK; Cheong GW; Lee JR; Jang MK
Molecules; 2019 Dec; 24(24):. PubMed ID: 31842508
[TBL] [Abstract][Full Text] [Related]
24. Intragenic Antimicrobial Peptide Hs02 Hampers the Proliferation of Single- and Dual-Species Biofilms of
Bessa LJ; Manickchand JR; Eaton P; Leite JRSA; Brand GD; Gameiro P
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340580
[No Abstract] [Full Text] [Related]
25. Effect of ion-bombarded silicone tympanostomy tube on ciprofloxacin-resistant Pseudomonas aeruginosa biofilm formation.
Jang CH; Cho YB; Choi CH
Int J Pediatr Otorhinolaryngol; 2012 Oct; 76(10):1471-3. PubMed ID: 22819832
[TBL] [Abstract][Full Text] [Related]
26. Next science wound gel technology, a novel agent that inhibits biofilm development by gram-positive and gram-negative wound pathogens.
Miller KG; Tran PL; Haley CL; Kruzek C; Colmer-Hamood JA; Myntti M; Hamood AN
Antimicrob Agents Chemother; 2014 Jun; 58(6):3060-72. PubMed ID: 24637684
[TBL] [Abstract][Full Text] [Related]
27. Effect of vancomycin-coated tympanostomy tubes on methicillin-resistant Staphylococcus aureus biofilm formation: in vitro study.
Jang CH; Park H; Cho YB; Choi CH
J Laryngol Otol; 2010 Jun; 124(6):594-8. PubMed ID: 20056010
[TBL] [Abstract][Full Text] [Related]
28. The Effect of Lysozyme on Reducing Biofilms by Staphylococcus aureus, Pseudomonas aeruginosa, and Gardnerella vaginalis: An In Vitro Examination.
Hukić M; Seljmo D; Ramovic A; Ibrišimović MA; Dogan S; Hukic J; Bojic EF
Microb Drug Resist; 2018 May; 24(4):353-358. PubMed ID: 28922066
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antibiofilm efficacy of various commercial antiseptics, enzymes and EDTA: a study of Pseudomonas aeruginosa and Staphylococcus aureus biofilms.
Lefebvre E; Vighetto C; Di Martino P; Larreta Garde V; Seyer D
Int J Antimicrob Agents; 2016 Aug; 48(2):181-8. PubMed ID: 27424598
[TBL] [Abstract][Full Text] [Related]
30. Influence of biofilm growth age, media, antibiotic concentration and exposure time on Staphylococcus aureus and Pseudomonas aeruginosa biofilm removal in vitro.
Chen X; Thomsen TR; Winkler H; Xu Y
BMC Microbiol; 2020 Aug; 20(1):264. PubMed ID: 32831025
[TBL] [Abstract][Full Text] [Related]
31. Increased resistance of contact lens-related bacterial biofilms to antimicrobial activity of soft contact lens care solutions.
Szczotka-Flynn LB; Imamura Y; Chandra J; Yu C; Mukherjee PK; Pearlman E; Ghannoum MA
Cornea; 2009 Sep; 28(8):918-26. PubMed ID: 19654521
[TBL] [Abstract][Full Text] [Related]
32. Combination of Silver Nanoparticles and Curcumin Nanoparticles for Enhanced Anti-biofilm Activities.
Loo CY; Rohanizadeh R; Young PM; Traini D; Cavaliere R; Whitchurch CB; Lee WH
J Agric Food Chem; 2016 Mar; 64(12):2513-22. PubMed ID: 26595817
[TBL] [Abstract][Full Text] [Related]
33. The ionic liquid 1-alkyl-3-methylimidazolium demonstrates comparable antimicrobial and antibiofilm behavior to a cationic surfactant.
Venkata Nancharaiah Y; Reddy GK; Lalithamanasa P; Venugopalan VP
Biofouling; 2012; 28(10):1141-9. PubMed ID: 23092364
[TBL] [Abstract][Full Text] [Related]
34. The use of piperacillin-tazobactam coated tympanostomy tubes against ciprofloxacin-resistant Pseudomonas biofilm formation: an in vitro study.
Jang CH; Park H; Cho YB; Choi CH; Park IY
Int J Pediatr Otorhinolaryngol; 2009 Feb; 73(2):295-9. PubMed ID: 19095310
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of biofilm formation by esomeprazole in Pseudomonas aeruginosa and Staphylococcus aureus.
Singh V; Arora V; Alam MJ; Garey KW
Antimicrob Agents Chemother; 2012 Aug; 56(8):4360-4. PubMed ID: 22664967
[TBL] [Abstract][Full Text] [Related]
36. Development of Chitosan-Based Surfaces to Prevent Single- and Dual-Species Biofilms of
Lima M; Teixeira-Santos R; Gomes LC; Faria SI; Valcarcel J; Vázquez JA; Cerqueira MA; Pastrana L; Bourbon AI; Mergulhão FJ
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299652
[TBL] [Abstract][Full Text] [Related]
37. Effect of blood and mucus on tympanostomy tube biofilm formation.
Malaty J; Antonelli PJ
Laryngoscope; 2008 May; 118(5):867-70. PubMed ID: 18520185
[TBL] [Abstract][Full Text] [Related]
38.
Yadav MK; Chae SW; Go YY; Im GJ; Song JJ
Front Cell Infect Microbiol; 2017; 7():125. PubMed ID: 28459043
[No Abstract] [Full Text] [Related]
39. Antimicrobial and antibiofilm potential of Curcuma longa Linn. Rhizome extract against biofilm producing Staphylococcus aureus and Pseudomonas aeruginosa isolates.
Suwal N; Subba RK; Paudyal P; Khanal DP; Panthi M; Suwal N; Nassan MA; Alqarni M; Batiha GE; Koirala N
Cell Mol Biol (Noisy-le-grand); 2021 Jan; 67(1):17-23. PubMed ID: 34817373
[TBL] [Abstract][Full Text] [Related]
40.
Orazi G; O'Toole GA
mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
